» Articles » PMID: 27412325

Tripartite Motif Containing 28 (TRIM28) Promotes Breast Cancer Metastasis by Stabilizing TWIST1 Protein

Overview
Journal Sci Rep
Specialty Science
Date 2016 Jul 15
PMID 27412325
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

TRIM28 regulates its target genes at both transcriptional and posttranscriptional levels. Here we report that a TRIM28-TWIST1-EMT axis exists in breast cancer cells and TRIM28 promotes breast cancer metastasis by stabilizing TWIST1 and subsequently enhancing EMT. We find that TRIM28 is highly expressed in both cancer cell lines and advanced breast cancer tissues, and the levels of TRIM28 and TWIST1 are positively correlated with the aggressiveness of breast carcinomas. Overexpression and depletion of TRIM28 up- and down-regulates the protein, but not the mRNA levels of TWIST1, respectively, suggesting that TRIM28 upregulates TWIST1 post-transcriptionally. Overexpression of TRIM28 in breast cancer cell line promotes cell migration and invasion. Knockdown of TRIM28 reduces the protein level of TWIST1 with concurrent upregulation of E-cadherin and downregulation of N-cadherin and consequently inhibits cell migration and invasion. Furthermore, Immunoprecipitation and GST pull-down assays demonstrated that TRIM28 interacts with TWIST1 directly and this interaction is presumed to protect TWIST1 from degradation. Our study revealed a novel mechanism in breast cancer cells that TRIM28 enhances metastasis by stabilizing TWIST1, suggesting that targeting TRIM28 could be an efficacious strategy in breast cancer treatment.

Citing Articles

TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies.

Eberhardt W, Nasrullah U, Pfeilschifter J Cells. 2025; 14(2).

PMID: 39851496 PMC: 11764315. DOI: 10.3390/cells14020065.


Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management.

Dong Y, Bao G Open Life Sci. 2024; 19(1):20221001.

PMID: 39655193 PMC: 11627072. DOI: 10.1515/biol-2022-1001.


Multifaceted role of in health and disease.

Maghsoudloo M, Mokhtari K, Jamali B, Gholamzad A, Entezari M, Hashemi M MedComm (2020). 2024; 5(11):e790.

PMID: 39534556 PMC: 11554878. DOI: 10.1002/mco2.790.


XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.

Jang S, Choi H, Ahn J, Jang S, Yoon J, Lee M Mol Biomed. 2024; 5(1):58.

PMID: 39532800 PMC: 11557793. DOI: 10.1186/s43556-024-00224-9.


The tripartite motif-containing 24 is a multifunctional player in human cancer.

Yao Y, Zhou S, Yan Y, Fu K, Xiao S Cell Biosci. 2024; 14(1):103.

PMID: 39160596 PMC: 11334367. DOI: 10.1186/s13578-024-01289-3.


References
1.
Pinho A, Rooman I, Real F . p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells. Cell Cycle. 2011; 10(8):1312-21. DOI: 10.4161/cc.10.8.15363. View

2.
El Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D . Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet. 1997; 15(1):42-6. DOI: 10.1038/ng0197-42. View

3.
Bunch H, Zheng X, Burkholder A, Dillon S, Motola S, Birrane G . TRIM28 regulates RNA polymerase II promoter-proximal pausing and pause release. Nat Struct Mol Biol. 2014; 21(10):876-83. PMC: 4189995. DOI: 10.1038/nsmb.2878. View

4.
Tania M, Khan M, Fu J . Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumour Biol. 2014; 35(8):7335-42. DOI: 10.1007/s13277-014-2163-y. View

5.
Yang J, Weinberg R . Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008; 14(6):818-29. DOI: 10.1016/j.devcel.2008.05.009. View